FibroBiologics

FibroBiologics FibroBiologics holds 270+ patents.

Based in Houston, FibroBiologics is a clinical-stage biotechnology company developing a pipeline of treatments and seeking potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials.

FibroBiologics (Nasdaq: FBLG) announced that the USPTO has issued a Patent titled: Therapeutic Use of Fibroblasts for Us...
09/03/2026

FibroBiologics (Nasdaq: FBLG) announced that the USPTO has issued a Patent titled: Therapeutic Use of Fibroblasts for Use in Wound Healing. The patent covers methods of treating and accelerating the healing of wounds by topically administering a composition comprising 3D spheroid fibroblasts or fibroblast-derived materials.

The covered wound types span diabetic foot ulcers, venous leg ulcers, pressure wounds, bedsores, burns, cuts, and abrasions. In preclinical studies described in the patent, treated wounds healed significantly faster than controls in both diabetic and non-diabetic models. These findings are preclinical, and safety and efficacy have not been established.

For more information, please visit: https://bit.ly/4gMuEsZ

09/03/2026

There’s a small organ behind your breastbone with a very important job: helping train your immune system.

The thymus plays a central role in the development of T cells, which help the body identify and respond to threats. But as we age, the thymus gradually shrinks and much of its functional tissue is replaced by fat.

That age-related process is one reason researchers are studying the connection between the thymus, immune function, and healthy longevity.

At FibroBiologics, thymus science is one area being explored as part of our broader fibroblast research.

NASDAQ: FBLG

👉 See the full presentation behind the research: bit.ly/how-immunity-ages

Fibroblasts are everywhere in the human body, yet they have received far less attention than stem cells in regenerative ...
09/02/2026

Fibroblasts are everywhere in the human body, yet they have received far less attention than stem cells in regenerative medicine.

FibroBiologics is working to change that.

Our research is focused on understanding the regenerative and immune-modulating potential of fibroblasts and how these cells could open new possibilities for the treatment of chronic disease.
Sometimes the biggest opportunities in science come from looking more closely at what has been overlooked.

NASDAQ: FBLG

👉 Learn more: bit.ly/how-immunity-ages

09/01/2026

A stronger immune system isn’t always a smarter immune system.

For decades, many treatments have approached immune dysfunction by turning the response either down or up. But both extremes can create challenges.

The bigger question is: what if the goal isn’t simply more or less immunity, but better immune balance?

That’s part of what FibroBiologics is exploring through fibroblast research, studying how these cells interact with and may help modulate the immune system.

You don’t want more immunity. You want smarter immunity.

NASDAQ: FBLG

👉 See the full presentation behind the research: bit.ly/how-immunity-ages

What if we could help the immune system rebuild one of its most important functions?FibroBiologics is exploring a thymus...
09/01/2026

What if we could help the immune system rebuild one of its most important functions?

FibroBiologics is exploring a thymus organoid approach designed to study whether selected cells can help support the production of T cells, a critical part of immune function.

This research is still preclinical, but it represents an exciting area of study at the intersection of immunology, aging, and longevity.

NASDAQ: FBLG

👉 See the full presentation behind the research: bit.ly/how-immunity-ages

08/27/2026

What does it take to build a thymus organoid?

At FibroBiologics, researchers combine fibroblasts, thymic epithelial cells, and T-cell progenitors to create a three-dimensional thymus organoid.

In preclinical research, these organoids:
Self-assemble without artificial scaffolds
Are ready in approximately three days
Can be frozen, thawed, and remain functional
Are designed for injection rather than surgery

In laboratory studies, the organoids activated the same biological signals used by a natural thymus and supported the development of functional T cells.

This work is part of our ongoing research into immune longevity and regenerative medicine.

NASDAQ: FBLG
Follow along as we continue exploring the future of fibroblast science.

What if some of the most promising discoveries in medicine have been inside us all along?Fibroblasts are the most abunda...
08/26/2026

What if some of the most promising discoveries in medicine have been inside us all along?

Fibroblasts are the most abundant cells in the human body, yet they've received far less attention than other cell types in regenerative medicine.

At FibroBiologics, we're advancing fibroblast research to better understand their potential in regenerative medicine and immune modulation. As research continues, these remarkable cells may help unlock new possibilities for the future of medicine.

Sometimes, the biggest breakthroughs begin with a different way of looking at biology.

NASDAQ: FBLG

👉 Follow along as we continue advancing fibroblast research.

08/25/2026

Somewhere behind your breastbone is an organ that's quietly changing with age.

It's called the thymus, and it plays a critical role in your immune system by training T cells to recognize potential threats while protecting healthy tissue.

As the thymus naturally declines over time, your body produces fewer new T cells, changing how your immune system functions as you age.

That's why FibroBiologics is researching new approaches to support immune longevity through thymus science.

NASDAQ: FBLG
Follow along as we explore the science behind healthy aging.

FibroBiologics (Nasdaq: FBLG) announced the appointment of Leigh Steinberg to its Board of Directors.Mr. Steinberg is wi...
08/24/2026

FibroBiologics (Nasdaq: FBLG) announced the appointment of Leigh Steinberg to its Board of Directors.

Mr. Steinberg is widely regarded as the most influential sports agent of his generation and the inspiration behind the Academy Award-winning film Jerry Maguire. Over a career spanning more than 50 years, he has been a pioneering advocate for human longevity and brain health, convening leading neurologists and athletes at brain health summits since 1994 to advance concussion awareness. He recently launched the Leigh Steinberg Foundation to fund research into neurological injury.

Read the news release: https://bit.ly/3UhpoGn

Living longer isn't the goal.Living healthier is.Healthy longevity isn't just about adding more years to life, it's abou...
08/24/2026

Living longer isn't the goal.
Living healthier is.

Healthy longevity isn't just about adding more years to life, it's about maintaining the immune function that helps keep us active, resilient, and healthy as we age.

At FibroBiologics, we're advancing research into fibroblasts, immune modulation, and thymus organoids to better understand the biology behind healthy aging.

Because more years only matter if they're healthy ones.

NASDAQ: FBLG

👉 Follow along as we continue advancing fibroblast research.

Address

Houston, TX

Website

Alerts

Be the first to know and let us send you an email when FibroBiologics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to FibroBiologics:

Shortcuts

Share

Category